Israel Leads World In Wastewater Reclamation, But Solution Is Not Perfect
Wastewater reuse has emerged as a trusty method to combat water scarcity, but contaminants are still being found, say Israeli researchers.
August 30, 2021
Israeli Biotech Startup CytoReason Teams Up With Swiss Pharma Firm Ferring For IBD Drugs
CytoReason said it plans to present insights on the top drug targets to provide new therapeutic options for IBD patients.
May 25, 2021
German Drugmaker Bayer To Test New Drugs With 3D-Printed Heart Tissues At TAU
As part of the agreement, Dvir's lab and Bayer will aim to test new cardiology medication for toxicity and efficacy.
June 28, 2020
Israeli Biotech Startup Combines Immunology, AI To Help Develop Better Drugs
Founded in 2016, CytoReason already has partnerships with top global pharmaceutical companies.
May 14, 2019
Data-Powered Drug Discovery Startup CytoReason Signs Deal With Pfizer
The company's propriety platform combines scientific and experimental data for immune system simulations applicable to cancer immunotherapy, and autoimmune, neurodegenerative and infectious disease research.
January 08, 2019
The Future Of Medicine: Israeli Scientists Unveil New Tech To 3D-Print Personalized Drugs
Researchers at the Hebrew University of Jerusalem have developed a new platform for drug creation and delivery, which they will present at the 3D Printing and Beyond conference.
November 06, 2018